Furthermore, CEBPB also interacts with FOXO1, NF-kappa B, and CCL20, and FOXO1/CEBPB/NF-kappa B/CCL20 axis has been reported as a target for Colorectal cancer treatment (106, 107). Here, CCL20 is linked to colorectal cancer.